cerca CERCA
Domenica 26 Settembre 2021
Aggiornato: 15:15
Temi caldi

Enrollment at Participating Hospitals In Europe

Karyopharm Announces Open Enrollment At Participating Hospitals In Europe For A Phase 3 Maintenance Study Evaluating Selinexor In Patients With Endometrial Cancer After Combination Chemotherapy

NEWTON, Mass., May 26, 2021 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that enrollment for its Phase 3 maintenance study evaluating selinexor in patients with endometrial cancer after combination chemotherapy is now recruiting eligible patients at participating hospitals in Belgium, Czech Republic, Germany, Italy, and Spain with Greece starting in the coming weeks. Full study details can...

ora in
Prima pagina
in Evidenza